Sangam Health Care Products Limited has intimated the BSE Limited about an upcoming meeting of its Board of Directors. The meeting is scheduled to be held on Friday, November 13, 2026, at the registered office of the Company.

The primary agenda for the board meeting includes:

  • Consideration and approval of the un-audited financial results for the quarter and half year ended September 30, 2026.
  • Consideration of the Limited Review Report for the quarter and half year ended September 30, 2026.
  • Any other business with the permission of the Chair.

The disclosure is made in compliance with Regulation 29(1)(a) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The letter is signed by D. Bhagat Reddy, Managing Director (DIN: 07087331), and is addressed to The Manager, BSE Limited, P. J. Towers, Dalal Street, Mumbai – 400001.